Histological and ultrastructural comparison of cauterization and thrombosis stroke models in immune-deficient mice by Mora-Lee, S. (Silvia) et al.
RESEARCH Open Access
Histological and ultrastructural comparison of
cauterization and thrombosis stroke models in
immune-deficient mice
Silvia Mora-Lee1†, Ma Salomé Sirerol-Piquer2†, María Gutiérrez-Pérez1, Tania López1, Mayte Casado-Nieto2,
Carlos Jauquicoam1, Gloria Abizanda1, Miriam Romaguera-Ros2, Ulises Gomez-Pinedo3, Felipe Prósper1* and
José-Manuel García-Verdugo2*
Abstract
Background: Stroke models are essential tools in experimental stroke. Although several models of stroke have
been developed in a variety of animals, with the development of transgenic mice there is the need to develop a
reliable and reproducible stroke model in mice, which mimics as close as possible human stroke.
Methods: BALB/Ca-RAG2-/-gc-/- mice were subjected to cauterization or thrombosis stroke model and sacrificed at
different time points (48hr, 1wk, 2wk and 4wk) after stroke. Mice received BrdU to estimate activation of cell
proliferation in the SVZ. Brains were processed for immunohistochemical and EM.
Results: In both stroke models, after inflammation the same glial scar formation process and damage evolution
takes place. After stroke, necrotic tissue is progressively removed, and healthy tissue is preserved from injury
through the glial scar formation. Cauterization stroke model produced unspecific damage, was less efficient and
the infarct was less homogeneous compared to thrombosis infarct. Finally, thrombosis stroke model produces
activation of SVZ proliferation.
Conclusions: Our results provide an exhaustive analysis of the histopathological changes (inflammation, necrosis,
tissue remodeling, scarring...) that occur after stroke in the ischemic boundary zone, which are of key importance
for the final stroke outcome. This analysis would allow evaluating how different therapies would affect wound and
regeneration. Moreover, this stroke model in RAG 2-/- gC -/- allows cell transplant from different species, even
human, to be analyzed.
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Background
To date, with the exception of tissue-type plasminogen
activator, there is no effective therapy for management
of acute stroke. Several animal stroke models have been
employed in order to develop new agents for treatment
of ischemic stroke. However, despite providing impor-
tant insights into the pathophysiology of the disease and
numerous potential therapeutic targets, the translation
of these results from bench to bedside has been disap-
pointing [1].
A reliable in vivo animal model of stroke must repro-
duce the etiology, anatomical, functional and metabolic
consequences of human disease as closely as possible.
Different focal and global ischemic models have been
developed and characterized in primates, dogs, gerbils
[2-4] and rodents [1,5]. Consensus has emerged in favor
of focal ischemic models and one of the most common
approaches relays in the occlusion of the middle cere-
bral artery (MCAo). Increasingly, intraluminal filament
MCAo in rats has been preferred over other species and
models. Although the use of recently developed
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transgenic mice has provided a potent new tool for
stroke research, the use of intraluminal filament in mice
is associated with a significant variability in infarct
volumes and increased incidence of complications,
which may be related to differences between strains and
ages, or even to minor technical differences.
In order to validate a model of ischemic stroke in new
transgenic mice, the effect of MCAo on tissue necrosis,
formation of glial scar and development of regenerative
process needs to be thoroughly assessed to determine
the pathophysiological mechanisms following permanent
or temporary MCAo and thus the potential effect of
therapeutic interventions.
Here we compare two different models of focal
ischemic stroke generated by MCAo cauterization or
ferric chloride induced thrombosis. BALB/Ca-RAG2-/-
gc-/-, immune-deficient mice are used to develop a
model permissive for cell therapy with human cells.
Methods
Animals and Surgical Procedures
Adult (7week-old) male BALB/Ca-RAG2-/-gc-/- mice
were housed in a temperature-controlled room with
access to food and water ad libitum . All experiments
were performed in accordance with “Guide for the Care
and Use of Laboratory Animals”, and animal procedures
were approved by the University of Navarra.
Mice were anesthetized with 80-100 mg/kg ketamine
and 10 mg/kg xylazine. A small craniotomy was per-
formed, the dura was excised, and the middle cerebral
artery (MCA) exposed. Cauterization model: Once the
MCA was exposed a metallic forceps was introduced
surrounding the artery, then the cauterizer touched the
forceps for several minutes, producing the artery cauter-
ization (Figure 1A) [6]. The control group underwent
similar operative procedure; however the cauterizer
instead of touching the forceps was placed close to the
forceps. FeCl3 thrombosis model: Thrombus was
induced by 1min topical application of a small strip of
filter paper soaked with 20% FeCl3 with the adventitial
surface of the vessel (Figure 1B) [7,8]. In control group
0.9% saline was used. FeCl3 produces endothelial
damage and denudation, which leads to thrombin-fibrin
and platelet dependent thrombus formation probably
primarily via the collagen/GPVI axis [9,10].
Behavioral test
Behavioural analyses were performed 24hr, 48hr and
96hr after stroke according to the modified neurological
severity score test (mNSS) proposed by Chen [11]. Neu-
rological function was graded as 0 to 14 (normal score,
0; maximal deficit score, 14) by which motor and sen-
sory function; balance impairment and reflex abnormal-
ity were evaluated (Table 1).
TTC staining
24hr after stroke, mice were sacrificed and their
brains sliced into 6 serial coronal sections of 1 mm
thickness. Slices were stained with 2% TTC at 37°C
for 30min.
Tissue processing, staining and morphometric analysis
Four animals for each time point were sacrificed at dif-
ferent time points (48hr, 1wk, 2wk and 4wk) after
stroke. Animals were perfused intracardially with 4%
paraformaldehyde (PFA). Brains were removed, post-
fixed overnight (ON) and cryoprotected in 15% sucrose
ON. Subsequently, brains were frozen and coronally
cryostat-sectioned at 14 μm. 10 serial series (containing
1 section out of every 10) were prepared for volume
analysis and immunohistochemical quantifications
(Additional file 1).
Figure 1 Description of cauterization and thrombosis stroke
models. A-B) Photomicrographs of the surgical procedure in
cauterization and thrombosis stroke models respectively, leading to
the blood flow cessation. C) TTC staining.
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Immunostaining
Serial sections were incubated in blocking solution, fol-
lowed by an ON incubation at 4°C with the primary
antibody: rabbit anti-GFAP 1:250 (DakoCytomation);
mouse anti-BrdU, 1:50 (DakoCytomation); rat anti-
CD31, 1:500 (BD-Biosciences) or goat anti-Iba1, 1:200
(Abcam). For GFAP immunostaining sections were
rinsed and EnVisionTM-HRP conjugated system
(DakoCytomation) was used as secondary reagent.
Afterwards sections were incubated 30min in 0.1% Sir-
ius-red, dehydrated and mounted in DPX. For immu-
nofluorescence, sections were washed and incubated
for 1hr with the appropriated secondary antibody:
mouse-Cy3 or rabbit-FITC or goat-Cy3; 1:200 (Jack-
son-Immunoresearch).
Cell proliferation
To evaluate the activation of SVZ proliferation, a single
dose of BrdU (50 mg/kg) was injected 2hr before sacri-
fice (n = 4). For BrdU immunostaining sections were
incubated with 2N HCl 30min at 37°C and rinsed in 0.1
M borate buffer pH 8.5 for 15min. After this pretreat-
ment sections immunostaining was carried out following
the standard procedure mentioned above. BrdU+ cells in
the SVZ were counted blindly in (5-7) 14 μm coronal
section per animal, spaced 140 μm apart, under high
magnification. Results were expressed as the average
number of BrdU+ cells per section.
Neovascularization
Blood vessel density estimation was performed in the
ischemic boundary region using an Axioplan2-Zeiss
automated microscope. This region was delineated from
the edge of the pan-necrotic cystic cavity approximately
400 μm into the adjacent cortex. Within these bound-
aries four randomly fields at 10x magnification were
analyzed. Blood vessel density was estimated as the per-
centage of CD31+ area in 8 sections per animal, spaced
140 μm apart, in the ipsilateral hemisphere (n = 4).
Measurement of infarct volume
Infarct volumes were measured in 4 mice per stroke
model 48hr after stroke. One of each 10 serial sections
per animal was stained with 0.25% thionin. Similar levels
were selected ranging from +2.0 to -3.0 mm from
Bregma in the anterior-posterior axis, using the Paxinos
stereotaxis mouse atlas. The area of infarction (necrotic
tissue) and the area of both hemispheres were calculated
by tracing the area on the computer screen. To reduce
errors associated with processing of tissue for histologi-
cal analysis, the area of infarction in each section was
presented as the percentage of the infarct in comparison
to the area of the contralateral hemisphere. The accu-
racy to delimit the area of infarction was further ana-
lyzed by EM.
Tissue processing for semithin sections and electron
microscopy
For electron microscopy (EM), animals were perfused
with 2% PFA and 2.5% glutaraldehyde at different time
points (48hr, 1wk, 2wk and 4wk) after stroke. Three ani-
mals for stroke model and for each time point were
sacrified (Additional file 1). Brains were postfixed ON in
the same fixative and cut into 200 μm coronal sections.
Sections were post-fixed in 2% osmium tetroxide for
2hr, rinsed, dehydrated, and embedded in Durcupan.
Semithin-sections (1.5 μm) were cut with a diamond
knife and stained with 1% toluidine blue. Ultrathin-sec-
tions (60-70 nm) were cut, stained with lead citrate, and
examined under a FeiTecnai Spirit electron microscopy.
Semithin and ultrathin sections were obtained to analyze
the ischemic and penumbra evolution as well as the
activation of the SVZ at different time points after
stroke.
For SVZ EM analysis, the SVZ was photographed in
10 consecutive pictures. Photo merges for each SVZ
were performed with Photoshop. All the cells present in
the SVZ were identified and their nuclei traced and
painted using a different colour for each cell type in a
separated layer with Photoshop tools.
Statistical Analysis
Results are reported as the mean ± SD. Differences
between means were determined by Student’s t test,
Table 1 Modified Neurological Severity Score Test (mSCC)
(modified from Chen et al, 2001).
Raising rat by tail (normal = 0; maximum = 3) (3)
Flexion of forelimb 1
Flexion of hindlimb 1
Head moved > 10° to vertical axis within 30 s 1
Placing rat on floor (normal = 0; maximum = 3) (3)
Normal walk 0
Inability to walk straight 1
Circling toward the paretic side 2
Falls down to paretic side 3
Beam balance test (normal = 0; maximum = 3) (6)
Balances with steady figure (>60 s) 0
Grasps side of the beam 1
Hugs beam and 1 limb falls down from beam 2
Hugs beam and 2 limbs falls down from beam, or spins on
beam (>30 s)
3
Attempts to balance on beam but falls off (>20 s) 5
Attempts to balance on beam but falls off (>10 s) 6
Falls off, no attempt to balance or hang on the beam (<10 s)
Reflex absence and abnormal movements (normal = 0;
maximum = 2)
(2)
Pinna reflex (head shaken when meatus is touched) 1
Corneal reflex (eye blink when cornea is lightly touched with
cotton)
1
Maximum Points 14
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with P < 0.05 considered significant. The reproducibility
of the stroke in thrombosis and cauterization stroke
model were compared by the Sign-Test, with P < 0.05
considered significant.
Results
The mNSS test was used to evaluate neurological defi-
cits 24hr, 48hr and 96hr after MCAo in both models.
However, no significant differences were observed
between control and stroked animals. Thus, it was not
possible to implement a functional test for any of the
two models.
Assessment of stroke
The surgical procedures for cauterization and thrombo-
sis stroke models are depicted in figure 1A-B. Both
models have the advantage that MCAo is confirmed
directly through operative microscope and that the mor-
tality rate was low (13.9% and 7.8% respectively). In all
animals tested, physiological variables (temperature, pH,
pCO2) remained within normal range through the
observation period. To confirm the induction of stroke,
TTC staining was performed 24hr after the procedure.
In both models the infarction area is restricted to the
cortex and no changes were observed at the contralat-
eral hemisphere (Figure 1C). TTC staining pattern in
stroked BALB/c wt mice was equivalent to that observed
in RAG 2-/- gC -/- mice (data not shown).
Histopathological comparison between cauterization and
thrombosis model
To compare the glial scar formation and the evolution
of damaged tissue in both stroke models and to deter-
mine the best model for further analysis, brain semithin
and ultrathin sections were analyzed at different time
points after stroke (48hr, 1wk, 2wk and 4wk). The analy-
sis would allow evaluating how different therapies would
affect wound healing and regeneration after stroke in
future studies.
Morphological and pathological changes were similar
in both models and included the development of a pale
staining area of pan-necrosis after 48hr (Figure 2). The
wound was composed of necrotic edematous tissue with
shrunken neurons and neurons with a loss of cellular
integrity. The limit between healthy and necrotic tissue
was initially not well demarcated with a progressive loss
of cellular integrity from the healthy tissue towards
necrotic tissue (penumbra ). These observations were
confirmed by EM analysis showing necrotic areas char-
acterized by the presence of pyknotic neurons and cellu-
lar ghosts, where synaptic contacts were no longer
observed while there was abundant activated microglia
(Figure 3A). However, in the transition zone between
the necrotic area and the healthy tissue, more synaptic
contacts and higher plasmatic membrane integrity were
observed (Figure 3B). Due to inflammation numerous
neutrophils were observed within the vascular lumina
and associated with the blood vessel endothelium, close
to necrotic brain tissue (Figure 3C). However, macro-
phage activation was not observed at this time point.
One week after stroke, infarcts were well delineated
from the surrounding healthy area. Scattered foamy
macrophages were present in the infarct area and volu-
minous non-macrophage cells with light cytoplasm close
to elongated cells displayed parallel to the lesion (Figure
2). At EM level macrophage infiltration was confirmed,
showing that necrotic neurophil was composed of cellu-
lar debris (Figure 3D). Voluminous cells were identified
as hypertrophic astrocytes rich in intermediate filaments,
which displayed parallel to the lesion delimitating
healthy tissue from necrotic tissue. Sometimes, astro-
cytes were observed under mitosis (Figure 3E-F). An
infiltrate of macrophages with abundant vacuolated
cytoplasm occupied the majority of the lesion volume
after 2 weeks (Figure 3G). An increase in hypertrophic
astrocytes with large and thick cytoplasmic expansions
were observed displaying parallel to the lesion border
(Figure 3H-I). Some of these cells were also observed in
inner locations close to vacuolated macrophages.
By 4 weeks, a large cavity had formed in the region
occupied by necrotic tissue (Figure 2), although a small
portion of necrosis and connective tissue persisted along
the lateral aspects of the superficial portion of the
lesion. Necrotic tissue is progressively removed while
collagen fiber formation takes place; this led to a pro-
gressive increase in the size of the cavity. An imbricate
layer of hypertrophied astrocytes attached to one
another by tight junctions lined the cavity. In association
with connective tissue elements, such as fibroblasts and
collagen fibers, astrocytes processes form a base mem-
brane, with abundant tight junctions and hemidesmo-
somes, which resemble the normal membrane
superficial glia membrane (Figure 3J-M). Activated
macrophages and inflammatory response have decreased
due to necrotic tissue removal.
Examination of ipsilateral hemispheres from sham-
operated animals and contralateral hemispheres of
MCAo animals provided appropriate controls for histo-
logical changes observed following MCAo. Inflamma-
tion, glial scar formation and damage evolution
underwent equivalent progress in BALB/c wt mice com-
pared to RAG 2-/- gC -/- mice in both stroke models
(data not shown).
Although both models recapitulate similar mechan-
isms and pathways in the damage tissue evolution,
there were some differences between them: first, cau-
terization induced a non-specific injury in the cortex,
leading to macrophage infiltration and damaged tissue
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Figure 2 Damage evolution and glial scar formation in cauterization and thrombosis models. Photomicrographs of toluidine blue-stained
semithin-sections at different time points after stroke. For each time point the first picture represents a panoramic view of the whole
hemisphere. The area squared in this picture is depicted next at higher magnification. The last two represent details of the necrotic area and the
boundary ischemic zone. Black arrows point piknotic cells and cellular ghosts. White arrows point to macrophages. Black arrowheads point to
elongated cells and white arrows point to voluminous non-macrophage cells (TZ: transition zone; HT: healthy tissue; NT: necrotic tissue).
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Figure 3 EM details of damage evolution and glial scar formation. Micrographs at different time points after stroke. At 48hr the transition
zone (TZ) (A) is observed. Black arrows point to synaptic contacts and black stars indicate cellular ghosts (B). (C) shows a detail of infiltrating
neutrophils. At 1wk macrophages (white arrows) appear in the necrotic neuropil (D) and astrocytes (black arrows) delineate the lesion border (E).
In some cases mitoses of astrocytes are observed (F). At 2wk after stroke, large macrophages (black arrows) and infiltrated neurotrophils (white
arrows) occupy the majority of the lesion volume (G). Hypertrophic astrocytes with plenty of intermediate filaments (black arrows) display lining
the ischemic boundary (H-I). Black arrowheads indicate rough endoplasmic reticulum cisternae and white arrowheads point to small
dictiosomes. At 4wk after stroke, an imbricate layer of hypertrophied astrocytes composes the boundary of the ischemic zone (J-K). At higher
magnification these astrocytes appeared attached by tight junction (black arrows). L-M show a detail of astrocytes associated to collagen fibers,
forming a base membrane (BV:blood vessel; As:astrocyte).
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degradation (Figure 4A). In addition, numerous studies
have shown an activation of endogenous brain stem
cells in the SVZ after neuronal injury [12]. Unspecific
injury induced by cauterization could activate cell pro-
liferation in the SVZ, thereby masking the effects pro-
duced by stroke, which also activate SVZ proliferation
and the inflammatory processes [13-17]. Second, while
cauterization produced a stroke in 57.5% of the ani-
mals, thrombosis model produced 80%, which supports
thrombosis as a more reliable model (Figure 4B) (n =
40 mice per stroke model). Finally, the infarct volume
distribution was more homogeneous in thrombosis
model compared to cauterization model (Figure 4C).
For these reasons, thrombosis model was chosen for
further analysis.
Thrombosis stroke model characterization
Next and in order to characterize the healing process
after stroke immunostaining against collagen (Sirius-
Red), astrocytes (GFAP), vascular endothelial cells
(CD31) and microglia (Iba1) was performed.
An increase not only in astrocytes and GFAP fila-
ments, but also in collagen fibers was observed with
time. While sham group presented very low macrophage
activation due to meningeal breakage, a clear activation
with numerous astrocytes is observed 48hr after throm-
bosis induction. At 2wk, GFAP labeling is observed lin-
ing the lesion border while collagen fibers are secreted
parallel to the lesion. At 4wk three tissue layers were
observed; the outer one is mainly composed by collagen
fibers, the intermediate contains many hypertrophic
astrocytes and the inner one represents uninjured tissue
(Figure 5B).
Immunostaining against CD31 was performed to ana-
lyze blood vessel formation after stroke. Qualitative and
quantitative analysis show an increase in blood vessel
density at all time points analyzed compared to control
or sham mice. Interestingly, blood vessels grew and
branched towards the scar tissue (Figure 5C, E).
Under normal conditions, microglia are ramified,
showing a large number of processes. Activated micro-
glia take a rounded amoeboid shape, reducing the length
and number of processes (Figure 5F). Iba1 immunos-
taining showed different levels of activation of microglia
after stroke. Sham mice showed an increase in microglia
somata size in comparison with control animals, likely
related to the meningeal breakage. 48hr after stroke
showed maximum activation of microglia as indicated
by the rounded and amoeboid morphology, which was
coincidental with maximal degeneration and degradation
processes. At later time points microglia become pro-
gressively less activated (Figure 5D). This could be due
to cavitation, as necrotic tissue is progressively phago-
cyted and almost completely removed by 4 weeks.
Activation of SVZ proliferation after stroke
Previous studies have demonstrated that stroke
induced by MCAo leads to an increased SVZ cell pro-
liferation, from rodents (10-14, 27) to human [18]. To
determine if this feature was present in the thrombotic
model, BrdU was injected on the day of sacrifice. BrdU
quantifications showed a significant increase in cell
proliferation at all time points analyzed in animals suf-
fering from stroke compared to sham mice. This
increase peaks at 48hr after stroke and decreases with
time (Figure 6A).
Cell proliferation was confirmed by the analysis of the
upper third of the SVZ where a notable cell increase
was observed after 48 hours. This increase appeared as a
layer of 4-7 cells, which extends through the ventricular
wall. Such activation is observed up to 1wk after stroke
(Figure 6B) with a progressive decrease. Four weeks
after stroke the SVZ looked similar to control mice (Fig-
ure 6B). Ultrastructural reconstruction of the upper
third of the SVZ was performed to determine the con-
tribution of the different cells types to the SVZ activa-
tion. At 48hr and 1wk after stroke a notable increase in
the number of type-B cells (astrocytes), type-C (transient
Figure 4 Thrombosis vs cauterization stroke model . A-C) Photomicrographs of toluidine blue-stained semithin sections showing unspecific
damage in cauterization stroke model (A scale-bar = 200 μm, B scale-bar = 50 μm and C scale-bar = 100 μm). D) Quantification of stroke
incidence (*P < 0,05). E) Distribution of the ischemic lesion induced by cauterization (C) stroke model (dotted lined, n = 4: C1-4) and thrombosis
(T) stroke model (continuous line, n = 4: T1-4).
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Figure 5 Immunohistochemical analysis of tissue damage evolution after stroke. A) Diagram of the progressive tissue loss after stroke. B)
Immunostaining against GAFP (brown) and counterstained with Sirius-red (reddish) to show the glial scar formation with time; C)
Immunostaining against CD31 (green), which point an increase in blood vessel; D) Immunostaining against Iba1 (red) to study microglia
activation (scale-bar = 50 μm); E) Quantitative analysis of neovascularisation after stroke. F) Scheme of different stages of microglia activation
from less activated towards more activated.
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amplifying cells) and type-A (migrating cells) was
observed with a subsequent decrease throughout time
(Figure 6G). However, no differences were observed in
ependymal cells at any time point analyzed.
Frequent mitosis (Figure 6C) as well as numerous
type-C and type-A cells arranged in enlarged chains
(Figure 6D) at 48hr and 1wk after stroke indicates that
SVZ proliferation is highly activated. All the mitoses
observed belonged to type-B, C and A cells. Ependymal
cells were never observed undergoing mitosis. In addi-
tion, numerous enlarged astrocytes were observed
close to each other with many cytoplasmic organelles,
mainly polyribosomes (Figure 6E). Interestingly, these
astrocytes presented less intermediate filaments, their
Figure 6 SVZ activation after thrombotic stroke. A) SVZ quantification of BrdU+ cells at different time points (48hr, 1 wk, 2wk and 4wk). Cells
were counted in the ipsilateral side of ischemic brains and in non-ischemic brains. Data are represented as the mean ± SD (n = 5)(Student’s t
test ***P < 0,0005; **P < 0,005 and *P < 0,05). B) SVZ semithin sections indicating activation of the proliferation. C-F) Transmission electron
micrographs of common events in activation of proliferation. C shows two mitoses pointed by arrows. D shows a robust migrating chain
encircled by a line. E shows an accumulation of augmented astrocytes, pointed by arrows. F highlights an invaginated astrocyte. G) Coloured
reconstruction based on EM photomerged images showing the different cell types increase after stroke. Dark-blue: astrocytes, green: Type-C
cells, red: neuroblasts, grey: ependymal cells, yellow: neurons, violet: microglia and blue: blood vessels. There is a remarkable activation 48hr after
stroke with an increase in the number of type-B, type-C and type-A cells.
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nuclei showed 2-3 prominent nucleoli and frequently
the invaginated nuclear membrane flattened and
adopted a rod-like appearance (Figure 6F).
Discussion
Several models of global and focal stroke have been
developed in many animal species. Overall, focal models
with preference for MCAo, are regarded as the best
approach, given that focal ischemia affecting the MCA
territory is the most frequent type of stroke in humans.
Nevertheless, the use of transgenic mice to investigate
pathophysiological mechanisms after stroke requires the
development of a reproducible and relevant model for
stroke in mice mimicking the large cerebral throm-
boembolic stroke in human.
In the present study, we have compared two models of
focal cerebral ischemia in mice: FeCl3 thrombosis stroke
model and cauterization model. Despite similar infarct
sizes and mortality, thrombosis model showed advan-
tages over cauterization model related to the reliability
of the model. Furthermore, cauterization produced a
permanent ischemia, while the thrombosis model could
be amenable to the use of thrombolytic agents leading
to reperfusion.
Although both stroke models fail to reproduce the
type of stroke that occur in people, these models mimic
the type of injury, the post-lesion effects as well as the
pathophysiological processes after stroke (inflammation,
oxidative stress, scarring....), which are key of impor-
tance for the final stroke outcome. Thereby these stroke
models are useful to evaluate damaged tissue evolution
after stroke and the effect of stroke therapies in this
area. We intend to provide a morphological method for
stroke evaluation.
Mice exhibit notable interstrain differences in infarct
after MCAo [19-22]. Strain variability in both cerebral
vasculature and neuronal vulnerability can contribute to
these differences. Moreover, mouse strains have differ-
ences in many gene system expression [23]. Thus, the
use of new transgenic mice requires a detailed charac-
terization of the response to the insult. BALB/Ca-
RAG2-/-gc-/- mice were selected in this study to validate
a reproducible mouse model of stroke, which would
allow the use of human cells in an immune permissive
milieu allowing for cell therapy studies. In comparison
with other immunedeficient mice, BALB/Ca-RAG2-/-
gc-/- mice have no T and B cells, no NK activity and
impaired DC function [24,25], which make them suita-
ble for further cell transplant experiments, with cells
from different origins and species, including human
cells. A limitation in the model could be the analysis of
inflammation at very early stages after stroke, given the
transgenic characteristics of these mice, although no dif-
ferences were observed at the time points analyzed (1
week-4 week) after stroke, compared to BALB/c wt
mice. However, these mice also provide the possibility
to reconstitute the immune system with human cells
(humanized mice) [26], which would be useful to test
the role of the human immune system in stroke.
Following the acute stroke phase, the tissue undergoes
a remodeling process that results in (astro)glial scar for-
mation and cavitation. The transition zone that develops
after 48 hours surrounding the necrosis area shows a
progressive loss of cellular integrity from healthy tissue
towards necrotic tissue. This region may be non-func-
tional but viable and potentially reversible hours after
insult. Secondary energy failure and injury evolve in this
zone up to one week, where the limits between necrotic
and healthy tissue appear better delineated. In the
ischemic border zone surrounding the evolving infarct,
inflammatory responses and apoptotic programs are
activated that further contribute to injury development
[27-29]. In fact, 2 and 4 weeks after stroke astrocytes
were observed in inner positions close to the fibrotic
scar, suggesting the possibility that cavitation process
continues taking place after these time points. Our
results provide an exhaustive analysis of the histopatho-
logical changes that occur after stroke in the ischemic
boundary zone, which are of key importance for the
final stroke outcome. Therefore, therapies should be
conducted to minimize cavitation process firstly by pro-
tecting the transition zone avoiding the increase in
necrotic tissue and secondly, protecting the surrounding
healthy tissue from the continuous scarring process.
It has been described that age plays an important role
in the recovery of the brain from insult, since microglia
and astrocytes increase both in number and reactivity in
normal older subjects. Badan and colleagues and DiNa-
poli and colleagues described that the glial scar develops
abnormally early in the infarcted region of aged rats
when compared to young rats, thereby hampering the
functional recovery of surrounding nervous tissue into a
greater extent [30,31]. Aged animals recover more
slowly and less completely than young animals.
Although remodeling and neuronal degeneration are
accelerated in aged rats, there is no consensus in the
ultimate extent of brain cell loss whether it is or not sig-
nificantly different from aged to young animals [32-36].
It could be relevant describe and compare deeply the
remodeling and scar formation process in young and
aged animals and test stroke therapies in stroke models
in aged animals, given than age could be the clue for
some differences between experimental and clinical stu-
dies in aged humans [37].
Stroke in mice induces an increase in proliferation in
the SVZ as well as migration of newly generated neuro-
blasts toward the damaged are as an attempt of self-
repair [13,14,16,17,38]. Thrombotic stroke in our mice
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model also produced a stimulation of endogenous
neural precursor, which was observed by the presence of
numerous mitoses and the increase in type-B and type-
C cells and consequently in type-A cells and BrdU
quantification. Interestingly, type-B cells presented some
morphologic changes, such as a decrease in intermediate
filaments and an increase in ribosomes. These changes
point to a transition from type-B cells to type-C cells.
Despite SVZ activation and migration toward the
damaged area, the vast majority of neuroblast die pri-
marily by apoptoptic mechanism, and only a small pro-
portion are able to survive and differentiate into
neurons [13]. Neuroblast death may be related to the
fibrotic scar boundary environment that cannot provide
the appropriate trophic support for neuroblast survival
as well as their integration within the tissue. Therapies
aimed to improve environmental conditions in the scar
boundary should be developed first to protect tissue
from degeneration and last to potentiate neuroblasts
survival and integration.
Unfortunately, although both stroke models present
tissue necrosis and cavitation process with time, no neu-
rological defects were observed with the modified neu-
rological severity score test (mNSS). We think that no
behavioral deficits were found after ischemic insult
because of the type of lesion induced. This lesion is
small and localized to the parietal cortex. By one hand
mice recover very quickly after surgery and by other
hand the other intact hemisphere could be supplying
the neurological functions perhaps through callosum
connections and plasticity, as the lesion area is small
and the corpus callosum is not damaged. Another possi-
ble explanation is that although mNSS is one of the
most used neurological tests to evaluate the neurological
outcome after stroke, in this case as the lesion is small
and area-restricted, this test could not be sensible
enough due in part to the collaboration of the other
hemisphere, requiring another one more demanding or
precise.
Conclusions
In summary, we compare thrombosis and cauterization
stroke model, giving evidence in favor of the thrombosis
model. The major advantages of this model are 1) its
potential use in mice models, including transgenic ani-
mals; 2) the possibility to study the effects of cell based
therapies with cells from different origins and species,
even human, avoiding the rejection problem or even in
combination with neuroprotective compounds or
thrombolytic agents. The histological and ultrastructural
analysis performed should also be very useful to deter-
mine the potential effects of different cell therapies in
the remodeling process including fibrotic glial scar
formation and cavitation as well as the role of these
therapies in neurogenesis after stroke.
Additional material
Additional file 1: Experimental design. Diagram with the groups,
animal per group and time points analyzed.
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